momo-T/FIF Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : momo-T/FIF

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Miljenko Zuanic who wrote (11439)	12/21/2017 4:22:33 PM
From: Biotech Jim	Read Replies (1) of 12215

Yes, I know Hiroko!, but do not know anyone else at VKTX but that does not matter. I did know what you meant in the original question. That is why I played it safe, saying that I wanted to wait to see the early Ph2 data. I do know that Mark Erion was involved in the discovery of the molecules you mentioned. He is a very good med chemist, having now moved on to MRK in a big position. My med chem colleagues have a lot of respect for the Harvard trained Dr. Erion. At least one called him a genius. I wish that I had access to the long term tox reports. I would look at liver and kidney findings carefully if any. Do you know if there is a Data Monitoring Safety Board Committee for the NASH compound, and when those safety readouts will be?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next